hero section gradient
16 handpicked stocks

iPhone 17 Suppliers: Which Stocks May Benefit Most?

Apple's record-breaking iPhone 17 sales are creating a massive demand shock across its global supply chain. This theme focuses on the key component manufacturers and suppliers poised to benefit from the surge in production orders.

Author avatar

Han Tan | Market Analyst

Published on October 31

Your Basket's Financial Footprint

Summary data for 'The Apple Effect: Supply Chain Surge' basket

Key Takeaways for Investors:
  • Large-cap dominance generally implies lower volatility and performance that tends to track broader-market movements.
  • Treat this basket as a core holding—stable portfolio anchor rather than a speculative, short-term growth play.
  • Expect steady, long-term value rather than rapid, explosive gains; returns are likely gradual.
Total Market Cap
  • AAPL: $4.03T

  • TSM: $1.27T

  • ASML: $422.08B

  • Other

About This Group of Stocks

1

Our Expert Thinking

Apple's record-breaking iPhone 17 sales have created a massive demand shock rippling through the global technology supply chain. When Apple scales up production, its network of suppliers experiences substantial revenue growth from the surge in component orders. This presents a tactical investment opportunity to benefit from a major product cycle's success.

2

What You Need to Know

This group focuses on the upstream partners essential to Apple's manufacturing process - from semiconductor fabricators and equipment makers to assembly specialists. These companies provide critical technologies like advanced chips, camera modules, display components, and manufacturing services that make the iPhone possible.

3

Why These Stocks

Each company was handpicked by professional analysts based on their integral role in Apple's supply chain ecosystem. These aren't random technology stocks - they're the specific manufacturers, suppliers, and service providers that directly benefit when Apple's production orders surge following exceptional sales performance.

Why You'll Want to Watch These Stocks

🚀

Riding Apple's Record Wave

When Apple breaks sales records, its suppliers often see their biggest revenue surges. You're getting exposure to the companies directly benefiting from the iPhone 17's unprecedented success.

Supply Chain Momentum Building

The demand shock is creating a powerful ripple effect through the entire technology ecosystem. These aren't just any tech stocks - they're the specific companies receiving massive production orders right now.

🎯

Expert-Curated Winners

Professional analysts handpicked these suppliers based on their critical role in Apple's manufacturing process. Each company provides essential technologies that make the iPhone possible.

Get the full story on this Basket. Read our detailed article on its risks and potential.

Read Full Insight

Why Invest with Nemo Money?

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

💰

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Opportunities

Automotive Semiconductor Gap Explained | Market Shift

Automotive Semiconductor Gap Explained | Market Shift

A major semiconductor supplier's export ban from China is halting vehicle production, creating a potential opening for other chip manufacturers. This theme identifies alternative semiconductor companies poised to fill the critical supply gap for the automotive industry.

Brazil Smart Farming Tech Investment Basket 2025

Brazil Smart Farming Tech Investment Basket 2025

As Brazil solidifies its role as a global agricultural leader, advanced technologies are unlocking new levels of productivity and sustainability for its farms. This basket offers exposure to the US and EU-listed companies providing the essential hardware, software, and data analytics driving this transformation.

Weight-Loss Drug M&A: Valuation Risk Concerns

Weight-Loss Drug M&A: Valuation Risk Concerns

Novo Nordisk's superior bid for Metsera has ignited a bidding war with Pfizer, highlighting the intense M&A activity in the obesity drug market. This theme focuses on other biotech companies with promising weight-loss therapies that could become the next acquisition targets.

Frequently Asked Questions